Analysen von Sachin Jain
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 09.02.21 | Bayer Neutral | Merrill Lynch & Co., Inc. | |
| 21.01.20 | Roche buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 13.09.19 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | Roche buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | Sanofi buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
|
Werbung
|
|||
| 13.09.19 | Merck Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Sanofi buy | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Merck Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 14.12.18 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 16.11.18 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Merck Neutral | Merrill Lynch & Co., Inc. | |
| 06.09.17 | Merck buy | Merrill Lynch & Co., Inc. | |
| 06.09.17 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 12.06.17 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 30.11.16 | Merck buy | Merrill Lynch & Co., Inc. | |
| 19.09.16 | Bayer Neutral | Merrill Lynch & Co., Inc. | |
| 08.09.16 | Merck buy | Merrill Lynch & Co., Inc. | |
| 19.05.16 | Bayer Neutral | Merrill Lynch & Co., Inc. | |
| 22.04.16 | Merck buy | Merrill Lynch & Co., Inc. | |
| 07.09.15 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 07.09.15 | Merck Underperform | Merrill Lynch & Co., Inc. | |
| 29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Merck Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Bayer Neutral | Merrill Lynch & Co., Inc. | |
| 14.11.14 | Merck Neutral | Merrill Lynch & Co., Inc. | |
| 03.04.14 | Bayer buy | Merrill Lynch & Co., Inc. | |
| 16.11.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
| 27.10.10 | Merck neutral | Banc of America Securities-Merrill Lynch | |
| 21.10.10 | Merck neutral | Banc of America Securities-Merrill Lynch | |
| 19.10.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
| 21.09.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
| 20.08.10 | Merck neutral | Banc of America Securities-Merrill Lynch | |
| 10.08.10 | Merck neutral | Banc of America Securities-Merrill Lynch | |
| 02.07.10 | AstraZeneca kaufen | Banc of America Securities-Merrill Lynch | |